AI echo analysis lifts detection of a hard-to-diagnose heart failure type to 78%
Adding an AI analysis of a single routine echocardiogram clip to a standard clinical score identified 78% of patients with confirmed heart failure with preserved ejection fraction (HFpEF), compared with 48% for the score alone, according to research in the November issue of the Journal of Cardiac Failure, the journal of the Heart Failure Society of America.
The researchers applied the AI model EchoGo HF to resting echocardiograms from 280 outpatients referred for suspected HFpEF, all of whom also had exercise hemodynamic testing, the diagnostic gold standard. The model added the most value for patients with low or intermediate H2FPEF scores, where diagnosis is hardest, so the authors tested a two-step approach: calculate the score first and use the AI only when it is inconclusive. An AI-detected HFpEF result also independently predicted higher filling pressures and lower exercise capacity.
The issue, which focuses on AI in heart failure, also includes a study in which researchers tuned OpenAI's o1 model on clinical notes from 599 patients to classify why eligible heart failure patients were not prescribed SGLT2 inhibitors, reaching 84.7% accuracy. Physician-related factors were the most common reason, led by deferring the decision to a later visit.
The guest editors call for prospective studies and, where feasible, randomised trials to test whether AI tools actually improve decisions, treatment and outcomes. "Promise alone is insufficient," they write, according to the society's announcement.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 17 Astromech acquires Form Bio in $230 million all-stock deal Nov 17 The Rx Assistant launches Builder, a no-code platform for pharma AI experiences Nov 17 Isomorphic Labs raises $5 billion Series C for AI drug design Nov 17 OpenAI says its computer-use agents can handle clinicians' EHR tasks, with CVS Health and Cigna among users Nov 16 FDA starts calling AI 'Super Intelligence' under Trump executive orderLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
Cleerly's AI plaque analysis beats usual chest-pain care in first randomised trial
Machine-learning models predict death risk after heart attack better than standard score
Taiwan hospital accelerator T+ MedIC names AI ECG and CT screening tools as first winners
93% of health systems now use AI, CHIME survey finds
Penguin Ai survey: 62% of patients facing prior authorization delays gave up on care
Daily AI Brief: the AI news that matters, in your inbox.